Validating the Safety and Effectiveness of ENDOANGEL Lower Gastrointestinal Endoscope Image Auxiliary Diagnostic Software
- Conditions
- Intestinal Polyps
- Interventions
- Other: Endoangel assisted the process of colonoscopyOther: Colonoscopy was performed without endoangel assistance
- Registration Number
- NCT05481632
- Lead Sponsor
- Ruijin Hospital
- Brief Summary
To evaluate the safety and effectiveness of ENDOANGEL Lower Gastrointestinal Endoscope Image Auxiliary Diagnostic Software developed and manufactured by Wuhan ENDOANGEL Medical Technology Co., Ltd.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1360
- 18 years old ≤ age ≤ 75 years old, male or female;
- Subjects with colonoscopy diagnosis and screening needs;
- Sign the Written Informed Consent Form;
- With full capacity for civil conduct.
- History of acute myocardial infarction (within 6 months), severe heart, liver, and renal insufficiency or mental disease;
- Patients who are taking aspirin, warfarin, and other anticoagulants;
- Patients with inflammatory bowel disease, or polyposis syndromes, or confirmed or highly suspected colon cancer;
- History of colorectal surgery;
- Patients with familial adenomatous polyposis;
- Pregnant women (if the subject is a woman of reproductive age and cannot confirm whether she is pregnant, a pregnancy test is required);
- Patients who are participating in clinical trials of other drugs or medical devices;
- Patients who are not eligible to participate in this clinical trial in the opinion of the investigator.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Physician AI-assisted diagnosis group Endoangel assisted the process of colonoscopy - Physician Independent Diagnostic Group Colonoscopy was performed without endoangel assistance -
- Primary Outcome Measures
Name Time Method sensitivity of polyps identification 3 months The numerator is the number of true positives and the denominator is the total number of true positives and false negatives.
specificity of polyps identification 3 months The numerator is the number of true negatives and the denominator is the total number of true negatives and false positives.
- Secondary Outcome Measures
Name Time Method Polyp detection rate 3 months The numerator is subjects with polyps detected and the denominator is all subjects.
Trial Locations
- Locations (1)
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
🇨🇳Shanghai, Shanghai, China